KANT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
KANT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Kineta's other inventories for the quarter that ended in Jun. 2024 was $0.00 Mil.
The historical data trend for Kineta's Inventories, Other can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kineta Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Inventories, Other | - | - | - | - |
Kineta Quarterly Data | |||||||||||||
Dec20 | Jun21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Inventories, Other | Get a 7-Day Free Trial | - | - | - | - | - |
Other inventories including goods for resale, stocks in transit, consignment stocks, etc.
Raymond J. Bartoszek | director | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Shawn Iadonato | director, officer: Chief Executive Officer | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Craig W. Philips | officer: President | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Pauline Kenny | officer: General Counsel | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Keith Baker | officer: Chief Financial Officer | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Thierry Guillaudeux | officer: Chief Scientific Officer | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Scott J. Dylla | director | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Marion R Foote | director | C/O KINETA, INC., 219 TERRY AVE. N., SUITE 300, SEATTLE WA 98109 |
Michael D Wyzga | officer: See Remarks | C/O YUMANITY, INC., 40 GUEST STREET, SUITE 4410, BOSTON MA 02135 |
Devin Whittemore Smith | officer: SVP and General Counsel | C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451 |
Kimberlee C Drapkin | director | PREDIX PHARMACEUTICALS HOLDINGS, INC., 4 MAGUIRE ROAD, LEXINGTON MA 02421 |
Ajay Verma | officer: EVP, Head of R&D | C/O CODIAK BIOSCIENCES, INC., 35 CAMBRIDGEPARK DRIVE, SUITE 500, CAMBRIDGE MA 02140 |
Lynne Zydowsky | director | C/O YUMANITY THERAPEUTICS, INC., 40 GUEST STREET, BOSTON MA 02135 |
Susan L. Lindquist Exempt Marital Trust | 10 percent owner | C/O NANCY E. DEMPZE, HEMENWAY & BARNES, LLP, 75 STATE STREET, BOSTON MA 02109 |
Susan L. Lindquist Massachusetts Non-exempt Marital Trust | 10 percent owner | C/O NANCY DEMPZE, HEMENWAY & BARNES, LLP, 75 STATE STREET, BOSTON MA 02109 |
From GuruFocus
By Marketwired • 08-19-2024
By Marketwired • 10-04-2023
By Marketwired • 09-28-2023
By GuruFocus Research • 02-07-2024
By GuruFocus Research • 02-07-2024
By Marketwired • 11-03-2023
By GlobeNewswire • 09-20-2024
By Marketwired • 09-25-2023
By Marketwired • 10-03-2023
By Marketwired • 09-19-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.